Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Biocompatibility Testing Services Market: By Type and Region Forecast 2020-2031
Biocompatibility Testing Services Market size was valued at US$ 9.8 billion in 2024 and is expected to reach US$ 18.4 billion by 2031, growing at a significant CAGR of 9.4% from 2025-2031. Due to increase in the research for the discovery of various types of medical devices. Moreover, due to the prevalence of various life threatening diseases, various new drugs and new devises are coming into the market those new products or devices need to be compatible with the human body, plastics and other polymers intended for use in medical devices, implants or other systems associated with a medical process, must be shown to be compatible with the human body these are the major factors that are driving the growth of the market over the forecast timeframe. An increase in the prevalence of various diseases such as cardiovascular diseases is a key factor drive.
According to World Health Organization, approximately 17.9 Mn death occurred due to cardiovascular diseases around the globe represents 31% of deaths around the globe and many people in developed countries are using heart stents and other medical devices to extend their lives for few more years. Moreover, these medical devices which are implanted in the human body must be biocompatible and the material that they use to make these devices like plastics, polymers also need to be biocompatible otherwise serious adverse effects may occur which may cause in death of the patient so biocompatibility testing should be performed and the raise in funding for the R&D activities by public and private sectors are anticipated to propel the market over the forecast years.
Study Period
2025-2031Base Year
2024CAGR
9.4%Largest Market
Asia-PacificFastest Growing Market
North-America
Report Benchmarks |
Details |
Report Study Period |
2025-2031 |
Market Size in 2024 |
US$ 9.8 billion |
Market Size in 2031 |
US$ 18.4 billion |
Market CAGR |
9.4% |
By Type |
|
By Region |
|
Download Free Sample Report
Biocompatibility testing services market size was valued at US$ 9.8 billion in 2024 and is expected to reach US$ 18.4 billion by 2031, growing at a significant CAGR of 9.4% from 2025-2031.
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The market key players Wickham Laboratories, North American Science Associates Inc., GLR Laboratories Pvt Ltd., Accuprec Research Labs Pvt. Ltd., Nelson Laboratories, Inc., Toxikon, Inc., Pacific BioLabs BioComp Laboratories, Inc., Morulaa HealthTech Pvt. Ltd., Geneva Laboratories.
1.Executive Summary |
2.Global Biocompatibility Testing Services Market Introduction |
2.1.Global Biocompatibility Testing Services Market - Taxonomy |
2.2.Global Biocompatibility Testing Services Market - Definitions |
2.2.1.Type |
2.2.2.Region |
3.Global Biocompatibility Testing Services Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Biocompatibility Testing Services Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Biocompatibility Testing Services Market By Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
5.1. Material Characterization, |
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Cytotoxicity, |
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Hemocompatibility, |
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Implantation Testing, |
5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Intracutaneous Reactivity, |
5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Sensitization, |
5.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
5.7. Systemic Toxicity, |
5.7.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.7.3. Market Opportunity Analysis |
5.8. Pyrogenecity, and |
5.8.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.8.3. Market Opportunity Analysis |
5.9. USP Plastics |
5.9.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.9.3. Market Opportunity Analysis |
6.Global Biocompatibility Testing Services Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
6.1. North America |
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Europe |
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Asia Pacific (APAC) |
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Middle East and Africa (MEA) |
6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Latin America |
6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7.North America Biocompatibility Testing Services Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
7.1. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
7.1.1.Material Characterization, |
7.1.2.Cytotoxicity, |
7.1.3.Hemocompatibility, |
7.1.4.Implantation Testing, |
7.1.5.Intracutaneous Reactivity, |
7.1.6.Sensitization, |
7.1.7.Systemic Toxicity, |
7.1.8.Pyrogenecity, and |
7.1.9.USP Plastics |
7.2. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
7.2.1.United States of America (USA) |
7.2.2.Canada |
8.Europe Biocompatibility Testing Services Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
8.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Material Characterization, |
8.1.2.Cytotoxicity, |
8.1.3.Hemocompatibility, |
8.1.4.Implantation Testing, |
8.1.5.Intracutaneous Reactivity, |
8.1.6.Sensitization, |
8.1.7.Systemic Toxicity, |
8.1.8.Pyrogenecity, and |
8.1.9.USP Plastics |
8.2. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Germany |
8.2.2.France |
8.2.3.Italy |
8.2.4.United Kingdom (UK) |
8.2.5.Spain |
9.Asia Pacific (APAC) Biocompatibility Testing Services Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
9.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Material Characterization, |
9.1.2.Cytotoxicity, |
9.1.3.Hemocompatibility, |
9.1.4.Implantation Testing, |
9.1.5.Intracutaneous Reactivity, |
9.1.6.Sensitization, |
9.1.7.Systemic Toxicity, |
9.1.8.Pyrogenecity, and |
9.1.9.USP Plastics |
9.2. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.China |
9.2.2.India |
9.2.3.Australia and New Zealand (ANZ) |
9.2.4.Japan |
9.2.5.Rest of APAC |
10.Middle East and Africa (MEA) Biocompatibility Testing Services Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Material Characterization, |
10.1.2.Cytotoxicity, |
10.1.3.Hemocompatibility, |
10.1.4.Implantation Testing, |
10.1.5.Intracutaneous Reactivity, |
10.1.6.Sensitization, |
10.1.7.Systemic Toxicity, |
10.1.8.Pyrogenecity, and |
10.1.9.USP Plastics |
10.2. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.GCC Countries |
10.2.2.South Africa |
10.2.3.Rest of MEA |
11.Latin America Biocompatibility Testing Services Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Material Characterization, |
11.1.2.Cytotoxicity, |
11.1.3.Hemocompatibility, |
11.1.4.Implantation Testing, |
11.1.5.Intracutaneous Reactivity, |
11.1.6.Sensitization, |
11.1.7.Systemic Toxicity, |
11.1.8.Pyrogenecity, and |
11.1.9.USP Plastics |
11.2. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Brazil |
11.2.2.Mexico |
11.2.3.Rest of LA |
12. Competition Landscape |
12.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
12.2.1.Wickham Laboratories |
12.2.2.North American Science Associates Inc., |
12.2.3.GLR Laboratories Pvt Ltd., |
12.2.4.Accuprec Research Labs Pvt. Ltd. |
12.2.5.Nelson Laboratories, Inc. |
12.2.6.Toxikon, Inc. |
12.2.7.Pacific BioLabs |
12.2.8.BioComp Laboratories, Inc., |
12.2.9.Morulaa HealthTech Pvt. Ltd. |
12.2.10.Geneva Laboratories |
13. Research Methodology |
14. Appendix and Abbreviations |
Key Market Players